Back to DE D. E. Shaw & Co., Inc.

PTCTPTCT
Showing 8 of 31 quarters

Position history for DED. E. Shaw & Co., Inc.'s holdings in PTC THERAPEUTICS INC

D. E. Shaw & Co., Inc. holds 1.5M shares of PTCT (PTC THERAPEUTICS INC), worth $126.3M as of 2026-Q2. The position was decreased (-5.6% shares). PTCT represents 0.1% of D. E. Shaw & Co., Inc.'s portfolio.

Current Value

$126.3M

Current Shares

1.5M

Total Value Change

+$73.7M

Total Shares Change

+129,380

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
1.5M
-5.6%
$126.3M0.1%$81.57
0
2026-Q1
Decreased
1.6M
-6.0%
$111.8M0.1%$64.39
0
2025-Q4
Decreased
1.7M
-19.8%
$132.5M0.1%$76.19
0
2025-Q3
Decreased
2.2M
-10.8%
$133.5M0.1%$60.65
0
2025-Q2
Increased
2.4M
+68.7%
$119.1M0.1%$49.84
45
2025-Q1
Decreased
1.4M
-6.3%
$73.7M0.1%$54.24
0
2024-Q4
Increased
1.5M
+8.7%
$69.6M0.1%$45.77
32
2024-Q3
Increased
1.4M
+4.6%
$52.7M0.0%$37.56
31

Other major holders of PTCT: BlackRock, Inc., VANGUARD GROUP INC, RTW INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used